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The putative role for vitamin D in muscle function and strength throughout the life course is of interest 33 
as muscle strength is required for engagement in physical activity at all ages.  As vitamin D deficiency 34 
is widely reported in the population, especially in countries at high latitude, the potential importance 35 
of vitamin D in muscle function throughout life, and potential impacts on growth and development, 36 
participation in physical activity and effects on skeletal and cardio-metabolic health, is an important 37 
topic for discussion.  This review provides an overview of muscle function and summarises the role 38 
of the vitamin D receptor and proposed molecular mechanisms of action of vitamin D in muscle cells.  39 
In addition, the review provides a comprehensive assessment of the clinical evidence surrounding the 40 
association between vitamin D and muscle strength.  Among adults, particularly older adults, cross-41 
sectional and cohort studies reported a positive association between vitamin D status and muscle 42 
strength.  These associations have been largely confirmed by intervention studies.  Limited research 43 
has been carried out in adolescents and children; two cross-sectional studies in adolescents have 44 
suggested an association between serum 25-hydroxyvitamin D concentrations and muscle strength.  45 
However, the two intervention studies in adolescents have yielded conflicting results.  Other than a 46 
single observational study, data in young children are very limited and further investigation in under 47 






The adverse outcomes of vitamin D deficiency, such as nutritional rickets in children and adolescents 51 
and osteomalacia and osteoporosis in adults, are well-documented (Institute of Medicine, 2011).  52 
However, vitamin D deficiency has also been linked with muscle weakness in both children and 53 
adults, suggesting additional indirect benefits of vitamin D on skeletal health beyond its well-54 
established role in calcium homeostasis (van der Heyden et al., 2004).  Muscle weakness, particularly 55 
affecting proximal muscles with symptoms such as delayed onset of walking in infants and difficulty 56 
climbing stairs in adolescents, is a clinical manifestation of vitamin D deficiency, which may coexist 57 
with skeletal features such as rickets and hypocalcaemia (Shaw and Mughal, 2013).  The aim of this 58 
review is to examine the association between vitamin D and muscle strength throughout the life 59 
course, with a particular emphasis on the available clinical evidence. 60 
 61 
Searches for this review were conducted in PubMed and Web of Science and terms (Mesh terms 62 
where applicable) included "Vitamin D" OR "Ergocalciferols" OR "Vitamin D Deficiency" OR 63 
"Cholecalciferol" OR "Vitamin D Receptor" AND "Muscles" OR "Muscle Strength" OR "Muscle 64 
Cells" OR "Muscle Development" OR "Muscle Weakness" OR "Genomic Pathway" OR "Non-65 
genomic Pathway".  A manual search of bibliographies of relevant primary journal articles was also 66 
conducted, with searches restricted to articles in English and citations up to June 2014.  67 
 68 
A brief summary of some studies in older adults has been provided, including results from meta-69 
analyses, as research into this area is well developed.  For younger adults, adolescents and children, 70 




Vitamin D 75 
Decreased serum 25-hydroxyvitamin D (25(OH)D) concentrations and vitamin D deficiency are 76 
widespread across the world with the highest rates of severe deficiency found in South Asia and the 77 
Middle East (van Schoor and Lips, 2011).  In Europe, there is much variability in serum 25(OH)D 78 
concentrations; a recent systematic review from Hilger et al. (2014) reported that the highest 79 




used, reliable and robust biomarker of vitamin D status (Seamans and Cashman, 2009).  Currently, 81 
there is no consensus among experts as to the definitive threshold concentration for vitamin D 82 
deficiency.  The US Institute of Medicine proposed that a serum 25(OH)D concentration of 50 nmol/L 83 
would cover the requirements 97.5% of the population for the maintenance of skeletal health and 84 
suggested a vitamin D deficiency cut-off value of 30 nmol/L (Institute of Medicine, 2011). 85 
 86 
Serum 25(OH)D concentrations are dependent on various factors, mainly cutaneous production in the 87 
presence of UVB and dietary intake.  There are a limited amount of foods containing naturally 88 
occurring vitamin D but some natural sources include oily fish, meat, dairy, egg yolk and mushrooms 89 
(Gonzalez-Rodriguez et al., 2013) and depending on legislation, some foods are fortified with vitamin 90 
D, including milk, yoghurt, spreads, cheese, juices, breads and breakfast cereals (Kiely and Black, 91 
2012).  However it appears that dietary sources alone cannot supply an individual with all their 92 
vitamin D needs (Heaney et al., 2003), with variations in vitamin D intakes from dietary sources 93 
occurring due to country specific fortification practices, sex, age, and supplement use practices 94 
(Cashman and Kiely, 2014).  Therefore the cutaneous production of vitamin D is a major determinant 95 
of serum 25(OH)D concentrations and vitamin D status.  However there are several environmental 96 
factors that impede year-round synthesis, such as latitude and prevailing weather conditions.  97 
Cutaneous production can also be affected by skin pigmentation, age, attire, sunscreen, working 98 
environment, physical activity and sun exposure behaviour (Kiely and Black, 2012). 99 
 100 
Muscle Contraction and Muscle Function 101 
To understand how vitamin D can impact on muscle function and strength, the mechanisms of action 102 
of muscle cells must be considered.  Muscle cells are composed of subunits called myofibrils and 103 
each myofibril is composed of smaller structures called myofilaments.  There are two main types of 104 
myofilament in muscle cells; thick filaments, composed of the protein myosin, and thin filaments, 105 
composed of the protein actin (Fox, 2009).  Filaments are arranged within subunits known as 106 
sarcomeres; the fundamental functional units of muscle.  The release of an action potential from the 107 
brain spreads into muscle fibres and causes a release of calcium ions (Ca2+) from the sarcoplasmic 108 
reticulum into the nearby actin-myosin complex.  Ca2+ binds to the protein troponin which results in 109 
excitation-contraction coupling of the muscle cell (Dulhunty, 2006).  Within the myosin filament, an 110 
adenosine triphosphate (ATP) molecule is split by myosin ATPase enzymes and the release of a 111 
phosphate results in a conformational change in the myosin filament, causing a cross-bridge with 112 




over each other, also known as muscle contraction.  The joining of a second ATP molecule to the 114 
myosin head results in the uncoupling of myosin and actin and thus muscle relaxation (Fox, 2009). 115 
 116 
Is the vitamin D receptor present in muscle? 117 
The active metabolite of vitamin D, 1,25 dihydroxyvitamin D (1,25(OH)2D) elicits its effects on 118 
calcium homeostasis through a vitamin D receptor (VDR); 1,25(OH)2D binds to the VDR on the cell 119 
cytosol resulting in a change in gene expression of that cell. VDR have now been located in more 120 
than 30 tissues in the body, not just tissues involved in calcium homeostasis (Zittermann, 2003).  121 
However, the presence of VDR in muscle tissue is still a debated topic.  One of the earliest studies by 122 
Simpson et al. (1985) in cultured rat muscle cells suggests that 1,25(OH)2D can act directly on muscle 123 
through a VDR that is similar to the receptors found in bone and the intestines.  Boland et al. (1985) 124 
demonstrated the presence of VDR in monolayers of chick myoblasts and Costa et al. (1986) 125 
demonstrated similar results in cloned human skeletal muscle cells.  In a study using VDR gene-126 
deleted mice, Endo et al. (2003) demonstrated that the absence of VDR in these mice caused muscle 127 
abnormalities, supporting the hypothesis of physiological roles of direct VDR actions on skeletal 128 
muscle cells.  Studies by Bischoff et al. (2001), Bischoff-Ferrari et al. (2004a) and more recently 129 
Ceglia et al. (2010) have demonstrated the presence of VDR in skeletal muscle cells using human 130 
muscle cell samples.  However, Wang and DeLuca (2011) have contradicted earlier findings 131 
demonstrating that VDR were not detected in skeletal, smooth or cardiac muscle, using human, mouse 132 
and rat muscle tissues.  They suggest that the function of vitamin D on muscle does not involve this 133 
receptor and may be of an indirect nature.  Despite some debate, it is widely thought that VDR are 134 
located in muscle cells and that the VDR acts as a mediator for 1,25(OH)2D to elicit its effects on 135 
muscle, however this is a point that requires further clarification. 136 
 137 
Three adjacent restriction fragment length polymorphisms for BsmI, ApaI, and TaqI at the 3′ end of 138 
the VDR gene have been extensively studied (Uitterlinden et al., 2004).  Most studies that have looked 139 
at musculoskeletal health have focused on the BsmӀ polymorphism.  Geusens et al. (1997) assessed 140 
quadriceps strength in 501 elderly women and those with the bb allele had maximal isometric strength 141 
23% higher than those with the BB allele and 12% higher than those with the Bb allele.  However, no 142 
such association was found by Windelinckx et al. (2007) in 493 adults in Belgium.  Other studies 143 
have identified the risk of falling as a measure of muscle strength.  Results from the ilSIRENTE study 144 
of 259 elderly men and women, found an association between the bb allele of the BsmӀ polymorphism 145 




were subsequently reported by Barr et al. (2010) in 2374 elderly women.  These studies suggest that 147 
an association between certain VDR gene polymorphisms and muscle strength may exist.  However, 148 
further research is required to confirm these findings and to provide further understanding of the role 149 
of VDR genetic polymorphisms in muscle function and strength. 150 
 151 
Molecular mechanisms of action of vitamin D in muscle tissue 152 
The mechanisms through which vitamin D can influence muscle function and strength are still unclear 153 
but it is thought that there are two main pathways through which 1,25(OH)2D functions: the genomic 154 
pathway and the non-genomic pathway.  Once 1,25(OH)2D has been transported to the nucleus of a 155 
muscle cell, it can elicit a slow, genomic transcriptional effect through binding to VDR, causing 156 
destabilization of a VDR complex in the VDR response element in the promoter region of a gene.  At 157 
the same time as this destabilization and in the presence of the retinoic receptor (RXR), the formation 158 
of the VDR–RXR heterodimer occurs (Cheskis and Freedman, 1994).  This heterodimer can then 159 
promote an interaction between the VDR’s zinc finger region and DNA, resulting in mRNA 160 
transcription and ultimately de novo protein synthesis (Freedman, 1999).  The synthesis of proteins 161 
including the calcium binding proteins calmodulin and calbindin D9K can be altered by the genomic 162 
pathway of 1,25(OH)2D.  These proteins are usually involved in muscle cell calcium uptake, muscle 163 
cell proliferation and differentiation and phospholipid metabolism (Ceglia, 2008). 164 
 165 
The rapid, non-genomic effects of 1,25(OH)2D are also thought to be mediated by VDR, as the 166 
presence of 1,25(OH)2D in muscle cells can induce the translocation of nuclear VDR into the plasma 167 
membrane of cells (Capiati et al., 2002).  Non-genomic effects of 1,25(OH)2D involve the activation 168 
of a number of cell signalling pathways including protein kinase C, calmodulin-dependent kinase and 169 
many others.  Calcium homeostasis is affected by the non-genomic pathway, as the actions of 170 
1,25(OH)2D can result in a rapid influx of calcium from the sarcoplasmic reticulum which can play 171 
a role in regulating muscle cell contractions.  Non-genomic effects of 1,25(OH)2D also include the 172 
stimulation of proliferation and differentiation of muscle cells, protection of skeletal muscle cells 173 
from insulin resistance and induction of the release of arachidonic acid which can alter cell membrane 174 
fluidity and permeability (Dirks-Naylor and Lennon-Edwards, 2011).  Although many of the non-175 
genomic effects of 1,25(OH)2D have been well described, there is still uncertainty as to how important 176 





Effects of vitamin D deficiency on muscle 179 
 180 
Vitamin D deficiency (25(OH)D < 30 nmol/L) can have adverse effects in both skeletal and cardiac 181 
muscle cells.  Dilated cardiomyopathy (DCM), secondary to severe vitamin D deficiency and 182 
hypocalcaemia, is a potentially fatal condition affecting cardiac muscle cells.  In a review of the 183 
prevalence of DCM in paediatric cardiology units in Southeast England, 16 cases of rickets-associated 184 
heart failure were seen over a six-year time frame.  Of these 16 cases, six of the infants had a cardiac 185 
arrest, two were referred for cardiac transplantation and a further three died.  Predisposing factors 186 
leading to the severe vitamin D deficiency that resulted in DCM were dark skin and exclusive 187 
prolonged breastfeeding, with the majority of cases presenting during British wintertime.  None of 188 
the infants or their mothers took vitamin D or calcium supplements during the pre- or postnatal period, 189 
however maternal serum 25(OH)D concentrations were not reported in many cases (Maiya et al., 190 
2008).  Subsequent case studies from Brown et al. (2009), Al Azkawi and Al Mutair (2012) and 191 
Sanyal and Raychaudhuri (2013) reported of infants presenting with DCM; further analysis revealed 192 
that they had rickets and severe hypocalcaemia due to vitamin D deficiency.  Treatment with calcium 193 
and vitamin D resulted in a rapid recovery of cardiac function in most cases. 194 
 195 
The focus of this review is vitamin D and skeletal muscle.  Muscle weakness and pain are 196 
characteristics of rickets and osteomalacia.  A detailed review of symptomatic vitamin D deficiency 197 
and rickets as well as muscle-related symptoms in affected children and adolescents, including 198 
reluctance to bear weight, pain and weakness has been provided by Shaw and Mughal (2013).  199 
Likewise in adults, muscle pain and weakness are also symptoms of vitamin D deficiency, which can 200 
result in more specific proximal muscle deficits, including an inability to climb stairs, lift objects or 201 
rise from a seated/squat position (Girgis et al., 2013).  Findings of muscle weakness and pain in the 202 
bone diseases rickets and osteomalacia are unsurprising; muscle and bone growth and development 203 
are closely connected.  Muscle is the main mechanical stimulus for bone tissue growth and 204 
development as they cause the largest load and strain on bone and this strain is essential for control 205 
of the biological mechanisms determining whole-bone strength (Frost and Schonau, 2000).  Much 206 
research is still required as little is known about the cellular interactions between muscle and bone, 207 
with a need to investigate muscle and bone interactions together as opposed to looking at each tissue 208 





Given the close interaction between muscle and skeletal development, there is a dearth of information 211 
on interactions between vitamin D status and bone and muscle development in children.  Among 212 
older adults, the clinical observational and experimental literature is relatively well developed albeit 213 
controversial. 214 
 215 
Older Adults 216 
Many of the studies performed in older adults have used lower extremity function tests to assess 217 
muscle strength, including walking speed/gait tests, chair stands and tandem tests.  Handgrip strength 218 
and thigh muscle strength as measured by a dynamometer have also been used.  An adverse health 219 
consequence of poor muscle strength or muscle weakness in older adults is the increased risk of 220 
falling.  Lean mass as measured using techniques including dual energy x-ray absorptiometry (DXA) 221 
has also been studied, with some studies suggesting a positive association between it and serum 222 
25(OH)D concentrations (Lee, 2013).  However, the focus of this review is on vitamin D and its 223 
effects on measures of muscle strength and function, not on the size of muscles.  In a large sample of 224 
4100 men and women aged ≥60 years, Bischoff-Ferrari et al. (2004b) showed better lower extremity 225 
functioning in adults with serum 25(OH)D concentrations ≥40 nmol/L compared with those with 226 
25(OH)D concentrations <40 nmol/L.  Similarly, Wicherts et al. (2007) found in 1234 men and 227 
women (mean age 75 years) that 25(OH)D concentrations <50 nmol/L were associated with lower 228 
scores for lower extremity functioning and a greater decline in physical performance over the three-229 
year study.  While 25(OH)D concentrations of 80 nmol/L or above have been suggested by some 230 
investigators (Dawson-Hughes, 2008, Dam et al., 2009) as optimal to promote muscle function in 231 
older adults, findings from observational studies have suggested that a serum 25(OH)D concentration 232 
of less than 50 nmol/L appears to detrimentally affect muscle function and strength. 233 
 234 
Findings from intervention studies in older adults are conflicting despite a multitude of literature in 235 
this age group.  Flicker et al. (2005) randomised 625 adults (mean age 83 years) to receive either 236 
placebo or vitamin D2 (10,000IU [250µg] once weekly initially and then 1,000IU daily) plus 600mg 237 
calcium for two years.  Those compliant with the vitamin D treatment had a reduced incidence of 238 
falls compared to the placebo group, regardless of baseline 25(OH)D concentrations.  Pfeifer et al. 239 
(2009) randomised 242 adults (mean age 77 years) to receive either 1000mg calcium or 1000mg 240 
calcium plus 800IU vitamin D3 daily for 12 months.  Vitamin D plus calcium supplementation 241 
significantly reduced the number of falls in participants compared to the calcium only treatment group 242 




functioning) were also reported in the vitamin D treatment group.  Zhu et al. (2010) randomised 302 244 
women (aged 70-90 years) to receive either 1000IU vitamin D2 plus 1000mg calcium or just 1000mg 245 
calcium daily for one year.  Increased muscle function (maximal contraction of various muscle types) 246 
was observed in those in the lowest tertile for baseline muscle strength in this group of women with 247 
baseline 25(OH)D concentrations <60 nmol/L. 248 
 249 
Conflicting findings were reported in a study of 243 older adults by Latham et al. (2003); participants 250 
were randomised to receive a single oral dose of 300,000IU vitamin D3 or placebo and muscle 251 
strength (lower extremity functioning) was assessed six months after supplementation.  There were 252 
no improvements in muscle strength measures after supplementation, even in those with 25(OH)D 253 
concentrations <30 nmol/L at baseline.  Janssen et al. (2010) randomised 70 females aged >65 years 254 
with baseline 25(OH)D concentrations <50 nmol/L to receive either 400IU vitamin D3 plus 500mg 255 
calcium or placebo plus 500mg calcium daily for six months.  Despite observing significant positive 256 
associations between 25(OH)D concentrations and muscle strength at baseline, there were no 257 
improvements in muscle strength in either treatment group after six months.  Glendenning et al. 258 
(2012) randomised 686 women (mean age 77 years) to receive 150,000IU vitamin D3 or placebo 259 
every three months for nine months.  Vitamin D supplementation was ineffective in reducing the 260 
number of falls in these women (mean baseline 25(OH)D of 65.8 nmol/L).  The high-dose intermittent 261 
supplementation regimen used in this study and by Latham et al. (2003) may explain the lack of effect 262 
on muscle strength as it has been suggested that high-dose supplementation may alter gene regulation 263 
and negate any beneficial effects of vitamin D on muscle metabolism.  Similar findings on dose 264 
regimen have been reported in a meta-analysis from Muir and Montero-Odasso (2011) where the 265 
authors suggest that supplemental daily doses of 800-1000IU of vitamin D demonstrate beneficial 266 
effects on muscle strength consistently, with inconsistent findings for high-dose treatments. 267 
 268 
The heterogeneity of studies in older adults carried out to date as highlighted here, have made it 269 
difficult to draw conclusions from their results, as differences exist in the study populations assessed, 270 
treatment durations, muscle strength measures, doses and types of vitamin D used and the use of 271 
additional supplementation including calcium.  These issues were highlighted in the recent report 272 
from the US Institute of Medicine and it declared that there was inconsistent evidence that vitamin D 273 
supplementation reduced the risk of falling in older adults (Institute of Medicine, 2011).  This finding 274 
is in contrast to many earlier studies including a meta-analysis by Bischoff-Ferrari et al. (2009) that 275 




the Institute of Medicine did claim that this particular meta-analysis was flawed in its choice of studies 277 
and its method chosen to explain the heterogeneity of studies.  Despite these conflicting arguments, 278 
further meta-analyses have suggested that daily vitamin D plus calcium supplementation can improve 279 
muscle strength and reduce the risk of falls, especially in individuals with 25(OH)D concentrations 280 
<25 nmol/L (Stockton et al., 2011, Murad et al., 2011).  Further large randomised controlled trials 281 
with standardised muscle strength measures are required to clarify the issues surrounding the role of 282 
vitamin D in muscle strength in older adults. 283 
 284 
Young Adults 285 
Until recently, much less research had been conducted in younger adults.  A recent observational 286 
study by Grimaldi et al. (2013) in 419 adults (mean age 44 years, 8% had 25(OH)D <50 nmol/L), 287 
observed a positive association between 25(OH)D concentrations and muscle strength, most notably 288 
for arm muscles.  A smaller study of 137 women aged 19 to 29 years (mean 25(OH)D of 54 nmol/L) 289 
also found a significant positive association between 25(OH)D concentrations and muscle strength 290 
(handgrip strength) (von Hurst et al., 2013).  Similar findings were reported in a very small study (n 291 
22) of Muslim women living in Canada with mean 25(OH)D concentrations of 36 nmol/L (Ojah and 292 
Welch, 2012).  Contrastingly, no association between 25(OH)D concentrations and muscle strength 293 
was found in a study of 1219 men (mean age 48 years) by Ceglia et al. (2011).  Reasons for these 294 
conflicting findings may be because the study population assessed by Ceglia et al. (2011) only 295 
consisted of males and the age range of participants was very broad (30-70 years), which is in contrast 296 
to the population groups assessed in other studies. 297 
 298 
Diamond et al. (2013) randomised 30 adults (25(OH)D at baseline <50 nmol/L) to receive either 2000 299 
or 5000IU vitamin D3 daily for three months; improvements in handgrip strength were observed in 300 
both treatment groups.  In India, 40 adults (mean age 31 years, 25(OH)D at baseline <50 nmol/L) 301 
were randomised to receive either placebo or 60,000IU vitamin D3 per week for the first eight weeks, 302 
followed by 60,000IU vitamin D3 per month for four months plus 1000mg calcium daily for six 303 
months.  Muscle strength (handgrip/thigh muscle strength, lower extremity functioning) increased 304 
significantly higher in the supplemented group compared to the placebo group (Gupta et al., 2010).  305 
However in a similar study performed subsequently by the same research group in 173 females (mean 306 
age 22 years), no significant change in muscle strength was observed following vitamin D and 307 
calcium supplementation (Goswami et al., 2012).  A reason for the lack of an effect may be that 308 




as when results from their earlier study were reanalysed by sex, it revealed that improvements in 310 
handgrip strength occurred only in males.  In a study of non-Western immigrant adults in Norway 311 
(mean 25(OH)D at baseline of 27 nmol/L), supplementation of 400 or 1000IU vitamin D3 daily for 312 
16 weeks did not improve muscle strength (handgrip strength, jump height) (Knutsen et al., 2014).  313 
Similar findings were also reported by Wicherts et al. (2011) in a study of non-Western immigrant 314 
adults in The Netherlands.  Contrastingly, a study in male athletes by Close et al. (2013) reported 315 
significant increases in muscle strength (jump height, endurance tests) after an eight-week 316 
intervention of 5000IU vitamin D3 daily, in the treatment group compared to the placebo group. 317 
 318 
Similarly to the findings in older adults, there are conflicting findings regarding younger adults, albeit 319 
less research has been conducted in this age group.  There is a need for further long-term intervention 320 
studies in this age group in both males and females to determine the role of vitamin D in muscle 321 
strength during early adult life. 322 
 323 
Adolescents and Children 324 
Currently, there are limited data available on the role of vitamin D in muscle strength in adolescents 325 
and children and most of the data that are available are in older children or adolescents (Table 1).  In 326 
an observational study of 99 post-menarchal females (aged 12-14 years), a positive association 327 
between 25(OH)D concentrations and muscle strength (jumping mechanography) was observed.  328 
Those with lower 25(OH)D concentrations generated less power during jumping and had lower jump 329 
height and velocity (Ward et al., 2009).  In another study of 301 females aged 15 years in China, 330 
participants with 25(OH)D concentrations >50 nmol/L had significantly greater handgrip strength 331 
compared to those with lower 25(OH)D concentrations, independent of body size, dietary intakes of 332 
vitamin D and calcium and levels of physical activity (Foo et al., 2009). 333 
 334 
El-Hajj Fuleihan et al. (2006) randomised 179 females aged 10-17 years (mean 25(OH)D at baseline 335 
of 35 nmol/L) to receive either 1400IU vitamin D3 per week (low dose), 14,000IU vitamin D3 per 336 
week (high dose) or a placebo weekly for one year.  There were significant increases in lean mass 337 
(measured by DXA) in both the low and high dose treatment groups compared to the placebo group, 338 
despite no significant change in handgrip strength between the treatment groups.  The changes in lean 339 
mass observed in this study perhaps suggest a direct effect of vitamin D on muscle size, however the 340 




slight changes in muscle strength in children and adolescents.  Seventy-three 12-14 year old females 342 
(25(OH)D at baseline <37.5 nmol/L) were randomised to receive either 150,000IU vitamin D2 or a 343 
placebo every three months for 12 months.  Mixed findings for muscle strength (jumping 344 
mechanography, handgrip strength) were observed, with improved jumping efficacy observed in the 345 
treatment group, but not jump power or force or handgrip strength (Ward et al., 2010).  These mixed 346 
findings for muscle strength may be explained by the suggestion by Glendenning et al. (2012) that 347 
intermittant high-dose supplementation may alter gene regulation and negate any beneficial effects 348 
of vitamin D on muscle metabolism.  The very limited evidence from intervention studies in 349 
adolescents and older children have produced conflicting findings.  Further research is required in 350 
this age group and in younger children to determine if vitamin D can impact on muscle strength in 351 
early childhood.  The focus of research should be to perform large randomised controlled trials in 352 
both males and females, providing daily/weekly vitamin D supplementation at a dose that will not 353 
have adverse health effects. 354 
 355 
Recently the relationship between intrauterine 25(OH)D exposure and muscle strength in children 356 
has been explored.  A study from the Southampton Women’s Survey reported a significant positive 357 
association between maternal 25(OH)D concentrations at 34-weeks’ gestation and height adjusted-358 
handgrip strength in their four-year old children (Harvey et al., 2014).  Findings from this study 359 
suggest that childhood muscle strength may also be influenced by maternal vitamin D status during 360 




Vitamin D deficiency is now widely recognised as a public health problem of growing concern, 365 
particularly for populations at increased risk due to high latitude, prolonged winter season, or other 366 
reasons for restricted UVB exposure and low vitamin D intake.  Apart from the acknowledged links 367 
between muscle myopathy and nutritional rickets and osteomalacia, there is evidence for a biological 368 
role for vitamin D in muscle function.  Much of the clinical studies have focused on older adults, 369 
where an association between serum 25(OH)D concentrations below 50 nmol/L and reduced muscle 370 
strength appears to be inconsistent.  Data among younger adults and adolescents are few and 371 
conflicted.  Partly due to the challenges involved in measuring muscle strength in young children, 372 
where methods such as jumping mechanography and lower extremity function tests can be difficult 373 




muscle strength in young children are required.  Due to these difficulties and some inconsistent 375 
findings, clinical guidelines on vitamin D for muscle strength and function are limited.  Current 376 
population guidelines regarding vitamin D are to avoid deficiency with the aim to have vitamin D 377 
intakes at the level of the Recommended Dietary Allowance (RDA) set by the national governing 378 
authority.  Despite recommendations, suboptimal serum 25(OH)D concentrations amongst 379 
adolescents and children have been reported all around the world, including India (Marwaha et al., 380 
2005), the Middle East (El-Hajj Fuleihan et al., 2006), North America and Canada (Newhook et al., 381 
2009, Sullivan et al., 2005), Ireland (Hill et al., 2008), the UK (Absoud et al., 2011) and throughout 382 
Europe (Gonzalez-Gross et al., 2012).  Therefore, the potential importance of vitamin D in muscle 383 
function and strength throughout life, impacting on normal growth and development, participation in 384 
physical activity and concomitant impacts on skeletal and cardio-metabolic health, is an important 385 
topic for discussion.  The aim of future research should be to further assess the importance of adequate 386 
serum 25(OH)D concentrations throughout the life course in the development of muscle and 387 
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Table 1 Vitamin D and muscle strength in children and adolescents 599 
Study No. of Subjects Age Sex 
Muscle Strength 
Measure Treatment Regimen Main Outcomes 
Cross-sectional       
Ward et al., 2009 99 12-14y Female Jumping Mechanography Not Applicable 
Significant positive association between 
25(OH)D concentrations and muscle 
power, force, velocity and jump height. 
Foo et al., 2009 301 15y Female Handgrip strength Not Applicable 
Participants with 25(OH)D 
concentrations >50 nmol/L had 
significantly greater handgrip strength 
compared to those with lower 25(OH)D 
concentrations. 
Harvey et al., 2014 678 4y Male  Female Handgrip strength Not Applicable 
Significant positive association between 
maternal 25(OH)D concentrations at 34-
weeks’ gestation and handgrip strength 
in their four-year old children. 
Intervention       
El-Hajj Fuleihan et al., 
2006 179 10-17y Female Handgrip strength 
1400IU vitamin D3 or 
14,000IU vitamin D3 or 
placebo weekly for 1 year 
No significant improvements in handgrip 
strength in either of the vitamin D 
treatment groups. 




150,000IU vitamin D2 or 
placebo every 3 months for 
12 months 
Improved jumping efficacy in the 
vitamin D treatment group, but no 
improvements in jump power, force or 
handgrip strength. 
25(OH)D, serum 25-hydroxyvitamin D; IU, international units 600 
